News
CitiusTech's John Edward discusses how AI can transform healthcare despite imperfect data, exploring Agentic AI, data quality ...
Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...
There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...
AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...
This article focuses on the common regulatory threads that connect different regions and the global standards and principles ...
AI and machine learning can transform fragmented and unstructured healthcare data. But how do you refine it into useful, ...
1d
Axios on MSNFDA's plan to roll out AI agencywide raises questionsThe Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...
Accelerated Timelines and Deployment Dr. Makary has set an ambitious timeline, directing all FDA centers to begin AI ...
For Charles Awoniyi, he stands at the forefront of healthcare transformation, leveraging his expertise in artificial ...
Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...
FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and ...
The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results